EDTA reduced the primary end point ( death , reinfarction , stroke , coronary revascularization , or hospitalization for angina ; 25 % versus 38 % ; hazard ratio , 0.59 ; 95 % confidence interval [ CI ] , 0.44-0 .79 ; P < 0.001 ) over 5 years .